Lizzy Van Tromp was four weeks pregnant when she was diagnosed with stage III breast cancer. Although her surgeon advised her to terminate, she continued with her treatment and her pregnancy.
After two decades of coping with advanced colorectal cancer, metastases in her lungs and liver, and a diagnosis of breast cancer, Margaret G. Werts, PhD, has learned how to maintain a sense of control and appreciate the small moments.
Amy Grantham talks about how blogging and writing and acting in a film based on her experiences helped her cope with breast cancer treatment and the transition back into “real life.”
In these two podcasts, Dr. Sundar Jagannath and Dr. Hope Rugo share the latest highlights in myeloma and breast cancer research.
The cost of cancer care is often a major source of stress for people with cancer. For some, these costs force them to make major lifestyle and medical care changes. Studies presented at both ASCO’s Palliative Care in Oncology and Quality Care Symposia shed more light on the financial challenges of cancer.
Breast cancer advocate Jody Schoger shares her experiences of presenting a poster and attending sessions at the 2014 Breast Cancer Symposium.
For early-stage breast cancer, doctors generally recommend surgery to remove the tumor. But choosing between a lumpectomy and mastectomy can sometimes be difficult. Deanna Attai, MD, FACS, a breast cancer surgeon, provides information and advice to help women talk with their doctors about this decision.
A large Canadian study finds that simply adding a doctor-signed letter to standard postcard reminders increases the chance that women will have their overdue mammogram screenings.
Learn how Angelina Jolie sharing her decision to have a preventive double mastectomy because she was a carrier of the BRCA mutation affected genetic counseling referrals and genetic testing rates at a Canadian cancer center.
New Insight on the Factors Affecting Local and Regional Recurrence from the 2014 Breast Cancer Symposium
Learn more about the results of a large study that has identified two factors that may help predict the chance that breast cancer will come back in the breast or nearby areas better than the cancer’s stage.